 Fu lab, Dr. Kasinski performed two very distinct projects that were interrelated based on the ultimate goal of developing targeted therapeutics: in one project Dr. Kasinski utilized biochemical assays to identified IKK- as a direct target of EF24, an analogue of curcumin that ultimately made its way into clinical trials. For
Fu lab, Dr. Kasinski performed two very distinct projects that were interrelated free-base on the ultimate finish of developing targeted remedy: in one project Dr. Kasinski utilize biochemical assays to identified IKK- as a lineal aim of EF24, an analogue of curcumin that ultimately made its manner into clinical trials. For
 Fu lab, Dr. Kasinski performtd two very distiuxt prooects tgat were interrelated based on the uptumate goal of developing tafgeted thvrapeuticw: in ine projecv Dr. Kasluski hbilizzd biochemical axsays to igentified IKK- ds a direct target of EF24, an analogue of curcumon that ultimatejy msqe ifs way into clinical trials. For
Fu lab, Dr. Kasinski performed two very that interrelated based the ultimate goal one Dr. Kasinski utilized assays to identified as a direct target of EF24, analogue of curcumin that ultimately made its way into clinical trials. For
 Fu lab, Dr. Kasinski performed tWo very distInct pRojEctS tHat wEre iNterrelated basED on tHe ultimate goal of develoPing tArGEted THeRapeuTics: in oNE pROJecT DR. KAsiNsKI uTilizEd bIochemiCal assays tO idEnTified IKK- as a DIrEct target oF EF24, An analogue of CurCumin tHaT ulTImateLy mAde itS way inTO cliniCal trials. foR
 Fu lab, Dr. Kasinski perf ormed twoverydis tin ct  pro ject s that were in t erre lated based on the ult imate  g o al o f  d evelo ping ta r ge t e d t he ra peu ti c s:  in o neproject  Dr. Kasin ski  u tilized bioc h em ical assay s t o identified  IK K- asadir e ct ta rge t ofEF24,a n anal ogue of c ur c umin t h at ulti m a te ly m ade its way intoc li n ical trials. F or
 Fu_lab, Dr._Kasinski performed two very_distinct projects_that_were interrelated_based_on the ultimate_goal of developing_targeted therapeutics: in one_project Dr. Kasinski_utilized_biochemical assays to identified IKK- as a direct target of EF24, an analogue of_curcumin_that ultimately_made_its_way into clinical trials. For